戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 um channel openers (KCO; e.g., diazoxide and pinacidil).
2  >100-fold less sensitive than WT vessels to pinacidil.
3  impaired lymphatic contractile responses to pinacidil.
4 ly sensitive to the K(ATP) channel activator pinacidil.
5 xide, whereas SUR2 channels are sensitive to pinacidil.
6  so by levcromakalim, and not depolarized by pinacidil.
7 elaxation induced by the KATP channel opener pinacidil.
8 nclamide, and responds to both diazoxide and pinacidil.
9 nsitive potassium (K(ATP)) channel activator pinacidil.
10 P current activated by the K+ channel opener pinacidil.
11 cker nisoldipine and the K(+) channel opener pinacidil.
12 s including high K(+), ACh, nitric oxide and pinacidil.
13 ually by 100 microM diazoxide and 100 microM pinacidil.
14 K+ ATP channel activation with intracoronary pinacidil (0.2-5.0 microgram/kg per min) increased flow
15 s control=25%, flunarizine=24% (P=0.44), and pinacidil=0.1% (P<0.001) and the percent of time stable
16                                              Pinacidil (1 microM) also activated an inwardly rectifyi
17 -fold by diazoxide (340 microM), 1.4-fold by pinacidil (1 mM) and unaffected by cromakalim (0.5 mM).
18 eplacement of the N-cyanoguanidine moiety of pinacidil (1, Figure 1) with a diaminocyclobutenedione t
19                                              Pinacidil 10 mumol/L had no effect in the rabbit and onl
20 In these cells, the potassium channel opener pinacidil (10 micromol/L) did not prevent Ca2+ loading (
21  cellular phenotype that, in the presence of pinacidil (10 micromol/L), expressed K+ current and gain
22 d ones, and the density of current evoked by pinacidil (100 microM), a K(ATP) channel opener, was sig
23                                 Responses to pinacidil (100 to 400 micromol/L), an opener of K(ATP) c
24          At a basic cycle length of 2000 ms, pinacidil (2 to 3 mumol/L) abbreviated the QT interval f
25 ardium but not endocardium after exposure to pinacidil (2 to 5 micromol/L), a K(+) channel opener, or
26                                              Pinacidil 25 mumol/L unexpectedly lessened the rise in [
27 sus CHx+IPC; P:<0.01) but not the effects of pinacidil (27+/-2% versus 29+/-3%, PIN versus CHx+PIN; P
28 h the K(+)(ATP) channel openers diazoxide or pinacidil 48 h prior to lethal ischemia protected hippoc
29  In contrast, these inhibitors did not alter pinacidil (5 microM)-induced dilation in SUR2(+/+) arter
30  with either Krebs-Henseleit solution (K-H), pinacidil (50 micromol/L in K-H), or hyperkalemic St.
31  probability (NP(o)) by 486 +/- 120% whereas pinacidil (500 microM) had no effect.
32  control=71%, flunarizine=48% (P<0.001), and pinacidil=56% (P<0.001).
33 rcentage recovery of developed pressure with pinacidil (60.3%+/-3.1%) was not statistically different
34                      In both groups of rats, pinacidil (a cyanoguanidine K(ATP) agonist; 0.3 to 300 m
35 infarcts was mapped during administration of pinacidil, a K(ATP) channel activator, directly into the
36                     Intrathecal injection of pinacidil, a KATP channel opener, significantly increase
37 pendent vasoconstriction that was relaxed by pinacidil, a selective K(ATP) channel opener.
38 vity was totally abolished by treatment with pinacidil, a specific opener of KATP channels.
39 s, the K(ATP) channel agonists diazoxide and pinacidil activated channels, and both compounds inhibit
40 nhibition and RNAi knockdown showed that the pinacidil activated KATP channels trigger signaling thro
41 e still functional in 10 mm d-glucose, since pinacidil-activated ATP-dependent K(+) (K(ATP)) currents
42 al K(ATP) currents by over 85% after 2 days (pinacidil-activated current densities were: vector alone
43                              The kinetics of pinacidil amide formation by CYP3A4 yielded an apparent
44 followed by cleavage of the O-O bond to give pinacidil amide.
45   ATP-sensitive potassium (KATP) activation (pinacidil) amplified the pulse-flow response 3-fold, alt
46     Ht31 reduced K(ATP) current activated by pinacidil and also prevented its inhibition by Rp-cAMPS,
47 (+) currents were augmented by minoxidil and pinacidil and attenuated by glibenclamide as well as tet
48 ide, activated the NCCa-ATP channel, whereas pinacidil and cromakalin did not.
49 n rabbit ventricular myocytes, we found that pinacidil and diazoxide open mitoK(ATP) channels, but P-
50                             KATP modulators (pinacidil and glibenclamide) or the specific Kir6.2-siRN
51 ic rats were 5- to 15-fold less sensitive to pinacidil and levcromakalim than were control arteries (
52  than were control arteries (EC50 values for pinacidil and levcromakalim were 1.4 and 0.6 mumol/L, re
53 ations to the synthetic KATP channel openers pinacidil and levcromakalim.
54                In the absence of nucleotide, pinacidil and P1075 activated Kir6.2/SUR2B and Kir6.2/SU
55 t for K(ATP)-channel openers (KCOs), such as pinacidil and P1075.
56 ronary arterioles to the KATP-channel opener pinacidil and to the endothelium-independent vasodilator
57  We studied the effects of 10 and 25 mumol/L pinacidil, and ATP-sensitive K channel opener that provi
58 KCl (5 to 20 mmol/L), bradykinin, adenosine, pinacidil, and sodium nitroprusside.
59 nels were sensitive to azide, diazoxide, and pinacidil, and their single-channel burst duration was 2
60 tive effects of diazoxide were reproduced by pinacidil, another mitoK(ATP) agonist, and blocked by th
61 tassium channel openers (PCOs) aprikalim and pinacidil are effective cardioplegic agents but exhibit
62 ocytes were exposed to simulated ischemia or pinacidil (ATP-sensitive potassium channel opener).
63 ene expression of selected M1 markers, while pinacidil augmented M1 markers.
64 onal restoration was determined by recording pinacidil-based KATP current by whole cell voltage clamp
65                                    Moreover, pinacidil, bradykinin, methacholine, and morphine failed
66 hannels are activated potently by 100 microM pinacidil but only weakly by 100 microM diazoxide; in ad
67                                              Pinacidil caused loss of action potential dome in male,
68 lphosphonium cation) and openers (diazoxide, pinacidil, chromakalim, minoxidil, testosterone) of the
69 [K+]e during ischemia, both before and after pinacidil, correlated with the time that the action pote
70 isolated cardiac mitochondria, diazoxide and pinacidil decreased the rate and magnitude of Ca2+ uptak
71                          Hearts treated with pinacidil demonstrated a rapid recovery of a coordinated
72 o not form functional cardiac KATP channels, pinacidil did not protect against hypoxia-reoxygenation.
73 e, 10(-4) M sodium nitroprusside or 10(-5) M pinacidil directly to capillaries initiated remote arter
74 , and KATP blocker profiling showed that the pinacidil DMR is due to the activation of SUR2/Kir6.2 KA
75                  Terfenadine, verapamil, and pinacidil each induced all-or-none repolarization at som
76 main peptide (SDP) also caused inhibition of pinacidil-evoked native whole-cell K(ATP) currents, indi
77                                              Pinacidil-evoked recombinant whole-cell Kir6.1/SUR2B cur
78  4.7% inhibition (mean +/- S.E.M.; n = 7) of pinacidil-evoked whole-cell KATP currents recorded in is
79                                              Pinacidil failed to activate current and the inward curr
80 uced by azide) plus a KCO (diazoxide for T1, pinacidil for T2).
81 O2 was significantly (P<.05) elevated in the pinacidil group (0.77+/-0.12) compared with the St Thoma
82 l)-2-nitroethene-1,1-diamin e (Bay X 9228) > pinacidil &gt; (-)-cromakalim > N-(4-benzoyl phenyl)-3,3,3-
83 exhibited a rank order of potency of P1075 > pinacidil &gt; levcromakalim = BMS-180448 > nicorandil > di
84 perpolarization and enhanced the response to pinacidil in arteries from diabetic animals.
85  channels preactivated by the channel opener pinacidil in rabbit ventricular myocytes, through reduci
86 2 channels were stimulated by cromakalim and pinacidil in the presence of ATP and Mg2+ but were insen
87                                Diazoxide and pinacidil, in a concentration-dependent manner, also act
88  channel openers (minoxidil, cromakalim, and pinacidil) increased cellular DNA synthesis, whereas K(A
89 that treatment with the KATP channel agonist pinacidil increases survival of bees while decreasing vi
90                              The response to pinacidil indicates that K(ATP) channels in the EBZ rema
91  molecular mechanisms by which diazoxide and pinacidil induce vasodilation by studying diameter regul
92               In summary, data indicate that pinacidil-induced vasodilation requires SUR2B, whereas d
93                       In SUR2(-/-) arteries, pinacidil-induced vasodilation was 10% of that in SUR2(+
94  Atpenin also attenuated diazoxide-, but not pinacidil-induced vasodilation.
95 with the DN Kir6.2 virus for 72 h suppressed pinacidil-inducible K(ATP) current density measured by w
96                                     Although pinacidil is a nonselective activator of expressed sK(AT
97               Some rats were pretreated with pinacidil (K+(ATP)channel opener), bradykinin, methachol
98             Glibenclamide (KATP blocker) and pinacidil (KATP opener) treatment not only affect macrop
99 mm extracellular glucose) but insensitive to pinacidil (&lt; or =500 microM).
100 atment also increased the phorbol ester- and pinacidil-mediated early preconditioning effect.
101 ner (PCO)-induced hyperpolarized arrest with pinacidil minimizes cellular energy requirements during
102 sensitive to potassium channel opener drugs (pinacidil, minoxidil) in both chambers of the heart and
103 sensitive to potassium channel opener drugs (pinacidil, minoxidil) in both chambers of the heart and
104  was repeated with the K(ATP) channel opener pinacidil (n=6) and the calcium channel blocker flunariz
105 for ATP, measured by its ability to slow the pinacidil off-rate, was also approximately 20 times high
106 nitol abolished the effects of diazoxide and pinacidil on mitochondrial Ca2+, while the K+ ionophore
107  activation increases the I(KATP) Induced by pinacidil or by MI.
108 ned with the ATP-sensitive K current agonist pinacidil or I(Ca,L) blocker verapamil to maintain AP du
109 only at reperfusion, the K(+) channel opener pinacidil or the antioxidants 2-mercaptopropionylglycine
110 ATP-sensitive K+ channel openers cromakalim, pinacidil, or diazoxide.
111  to KCl and bradykinin but not to adenosine, pinacidil, or nitroprusside.
112 reated using global infusion of ibutilide or pinacidil, or topical application of lidocaine.
113  (to 10-15%) by the K(ATP) channel activator pinacidil (PIN) but were absent in Ca(v)3 DKO vessels.
114 mia/5 minutes of reperfusion, n=6) or PPC by pinacidil (PIN, 10 micromol/L; n=6), an ATP-sensitive po
115 ion of NO donors, exogenous H2O2 potentiated pinacidil-preactivated sarcKATP channel activity in inta
116  conjunction with the KATP channel activator pinacidil, prevented intracellular Ca2+ loading irrespec
117                                  Unlike DZX, pinacidil promoted ischemia-mediated arrhythmias in both
118 levocromakalim (LCC), and to a lesser extent pinacidil, protect cultured rat hippocampal neurons agai
119                                              Pinacidil provided superior protection versus K-H (44.4%
120 plegic arrest and preconditioning induced by pinacidil provided superior recovery of contractile func
121 nticipated lessening of the rise in [K+]e by pinacidil reflects the balance of its effects on these s
122                                              Pinacidil restored conduction and excitability when the
123    In the presence of MgATP, the response to pinacidil reversed approximately 14 times more slowly wi
124   In hearts with an initially excitable EBZ, pinacidil shortened the effective refractory period and
125              Following channel activation by pinacidil, the catalytic fragment of PKC inhibited the K
126 izing ATP-sensitive potassium channel opener pinacidil, the protein kinase C activator 4 beta-phorbol
127 adine or verapamil to inhibit INa and ICa or pinacidil to activate IK-ATP.
128 ble for the conversion of the cyano group of pinacidil to the corresponding amide.
129              Cell shortening was enhanced in pinacidil-treated myocytes, but depressed in verapamil-t
130 ell phenotypic agonist profiling showed that pinacidil triggered characteristically similar dynamic m
131 l versus beta-cell channels to cromakalim or pinacidil versus diazoxide.
132 ve concentration for the KATP channel opener pinacidil was 10-fold higher.
133       In all stages of injury, the effect of pinacidil was inhibited by the selective antagonist of K
134                               The effects of pinacidil were completely reversed by glybenclamide (10
135 A, did not affect KATP currents activated by pinacidil when the intracellular solution contained 0.1
136 he benzopyran, cromakalim, and the pyridine, pinacidil, whereas an SUR1 segment which includes TMD6-1
137 >60%, but did not alter dilations induced by pinacidil, which did not elevate ROS.
138 y the SUR2-specific K(ATP) channel activator pinacidil, which hyperpolarized both mouse and human lym
139  blocker, glibenclamide, and was mimicked by pinacidil, which is a K(ATP) channel opener.
140                                Incubation of pinacidil with CYP3A4 in the presence of (18)O(2) or H(2
141                               Incubations of pinacidil with recombinant CYP enzymes confirm that CYP3

 
Page Top